Abstract
Introduction
Multiple sclerosis (MS) is the most common nontraumatic, disabling central nervous system (CNS) disease of young adults. 1, 2 Cognitive impairment (CI) affects a large proportion of these patients and is an important cause of permanent disability. 3, 4 However, full understanding of the pathophysiological mechanisms underlying MS-related CI remains incomplete.
Conventional and non-conventional magnetic resonance imaging (MRI) techniques have been correlated with CI in MS. [5] [6] [7] [8] MRI has improved our understanding of the relationship between lesions and disease manifestations, [9] [10] [11] but its role in the diagnosis of CI is not defined. Functional magnetic resonance imaging (fMRI) studies have shown significant correlations between abnormal signals and cognitive function across MS phenotypes compared to healthy controls (HC). Mainero et al. reported that "changes in functional organization of the cerebral cortex have been seen with fMRI studies comparing activation patterns during cognitive tasks, in patients with MS and HC." A study by Rocca et al. 12 on 17 primary progressive patients did not show structural MRI differences but found activation differences between those with CI and those intact; another study using the go-no go task was able to confirm adaptive changes of neuronal activation with progressing relapsing forms of MS. 10 Together, these provide evidence for the compensatory nature of the blood oxygenation level dependent (BOLD) activation patterns. 6, 10, 12 Recognizing that CI is not routinely assessed in the clinical setting, an international panel created The Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) battery, which evaluates all sensitive domains in CI, including working memory (WM), attention, and information processing (IP), the most commonly involved. 8, 13 Nevertheless, such specialized batteries are not routinely used in clinical practice. Recently, a short battery called the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) 14 was recommended for CI screening in the clinical setting; despite its ease of administration, BICAMS is not used routinely. Reliable MRI metrics to screen for early CI may facilitate interventions that could reverse, slow, or halt its progression, decreasing the burden of CI on MS patients.
fMRI is a useful tool to understand the pathophysiology of CI. 15 Sweet et al. using the two-back test evaluated verbal WM in MS, 16 concluding that high functioning patients showed greater activation in regions associated with verbal WM. 17 Chiaravalloti et al. 18 using the paced auditory serial addition test (PASAT) confirmed that WM dysfunction is associated with activation in cognition-related areas. In a review, Filippi et al. 4 concluded that fMRI has great potential to provide insight into cortical reorganization following damage from MS.
Although fMRI provides a better understanding of the cognitive constructs that underlie pathologic processes in CI, most paradigms do not evaluate varying degrees of WM nor have been validated by complete neuropsychological (NP) batteries. The immediate/ delayed memory task (I/DMT) paradigm yields more detailed information related to WM (which encompasses attention and IP), by detecting different degrees of impairment. It does so by alternating three levels of complexity of visual stimuli (3-, 5-, and 7-digit strings of numbers) for both immediate (0.5 seconds) and delayed (3.5 seconds) memory recall tasks (Figure 1) . Variation in task difficulty allows for comparison of the parametric levels within a single fMRI session, to enable determination of the relationship between task difficulty and BOLD activation. Moeller et al. 19 using I/DMT demonstrated less thalamic BOLD activation in cocaine-dependent subjects as compared to HC. This and other studies suggest that I/DMT may offer advantages in studying the effects of manipulating cognitive load on sustained attention when comparing HC and cognitively impaired patients. Although attention, IP, and WM are affected in MS-related CI, I/DMT has not been used to assess CI in this population.
In this cross-sectional study, 10 non-impaired multiple sclerosis patients (MSNI) and 40 multiple sclerosis patients with cognitive impairment (MSCI) underwent MACFIMS and an fMRI session performing I/DMT. The objective was to evaluate the capability of I/DMT to detect CI based on BOLD activation, specifically with respect to WM and to correlate results with those of MACFIMS. We hypothesized that I/DMT-based BOLD activation would differ between MSCI and MSNI patients and that classification into MSNI or MSCI by BOLD signal and I/DMT scores would correlate with MACFIMS classification.
Measures of T2 lesion load correlate with CI, but its role in BOLD activation has rarely been evaluated; therefore, the role of T2 lesion volume (LV) in the magnitude of BOLD signal was assessed. Correlations between disability and BOLD signal were also sought.
Materials and methods
A total of 10 relapsing-remitting (RR) MSNI and 40 MSCI patients (31 RR, 1 progressive relapsing, and 16, 20 or formal NP evaluation within 2 years of enrollment. Written informed consent was obtained from each patient following institutional review and approval of the research protocol. Patients underwent the MACFIMS battery 21 (Figure  2 ), followed by one fMRI session, which took place within 2-7 days from the MACFIMS. For exclusion criteria, see Supplementary Material.
fMRI session
Prior to imaging, patients underwent a 45-minute practice session in a "mock" scanner to familiarize themselves with the I/DMT. This paradigm has a parametric block design. The number of digits in the stimulus string can be 3, 5, or 7, and the number of digits per stimulus is held constant within each block. Similarly, the type of memory-delay condition is held constant within each block ( Figure 1 ). All three levels of the digit-load condition and two levels of the memory-delay condition are presented within each run. An IMT block is always followed by a DMT block with the same number of digits per stimulus. For more details on the I/DMT task, see Supplementary Material.
fMRI acquisition
Studies were performed using the in vivo eloquence system. The session included acquisition of a highresolution T1-weighted three-dimensional (3D) magnetization prepared rapid acquisition with gradient echo (MPRAGE) followed by three runs of the I/DMT. Spin-echo echo planar image (EPI) rather than gradient echo EPI was used, in order to avoid signal losses caused by strong susceptibility gradients (through slice de-phasing) in regions such as the medial orbitofrontal cortex [22] [23] [24] which is a sensitive area for evaluation of cognitive function by fMRI at 3 T, 23 based on the BOLD effect. 25 Each patient also underwent an MRI of the brain according to standard protocol (Table 2) .
fMRI processing and analysis AFNI and SPM8 software (MathWorks, Inc., Sherborn, MA, USA) were used. See Supplementary Material for details.
Quantitative MRI analysis
Image segmentation for tissue quantification was performed using software developed in-house 26 In brief, all images acquired were retrospectively aligned 27 and stripped of extrameningeal tissues, 28 then filtered using the anisotropic diffusion filter corrected for the bias field, 29 and intensity normalized. 30 Segmentation of gray matter (GM), white matter (WM), T2, and T1 LV were based on the dual echo and fluid attenuated inversion recovery (FLAIR) images using the hidden Markov random field-expectation maximization algorithm and Parzen window classification. 26 
Statistical analysis
For the block design I/DMT protocol, the IMT and DMT conditions for each digit-load condition were modeled by boxcar functions convolved with the SPM8 canonical hemodynamic response function. Parameters for each condition were estimated using the general linear model (GLM) at each voxel. The fMRI time series was high-pass filtered with a cutoff period of 330 seconds determined by Fourier transformation of each condition's time model. The working memory activation ("WMa") for each digit-load condition was defined as the DMT parameter estimate for that digit-load condition minus the IMT parameter estimate for that digitload condition. Comparison of activation between groups was conducted at the second level of analysis by entering one contrast image per subject into the SPM8 random effect procedure. This was implemented within the GLM using the SPM8 non-sphericity correction to correct for between-group heterogeneity of variance. Statistical significance was computed by SPM8, to correct for multiple comparisons over all the voxels in the brain. Areas of statistically significant differences in BOLD activation were identified using two-tailed family-wise error (FWE)-corrected cluster level, p < 0.05. Approximate anatomical labels for regions of activation were determined using the anatomical automatic labeling toolbox. 31 Regression analyses were conducted using the SPM8 second-level multiple regression module: (a) I/DMT activation on T2 LV, (b) I/DMT activation on DMT accuracy prime (A') scores, and (c) I/DMT activation on EDSS scores. For each regression analyses, the contributions of age, sex, education, DD, and disability were examined using stepwise multiple regression with forward selection, with p < 0.10 as the criterion for a variable to enter the regression model at each step, and p > 0.15 to leave the regression model at each step. In addition, the correlation of each of these individual variables with I/DMT activation was determined in a separate analysis. 
Results
The final sample consisted of 10 MSNI, 30 MSCI, and 4 MSBD patients. Since MSBD are partially impaired, analyses were performed both including and excluding MSBD. A total of six MSCI patients were excluded from the analyses due to lack of responses or head motion during I/DMT (Table 1 , shaded subjects).
I/DMT scoring by A′
MSNI patients had a mean A′ score similar to a previously evaluated medically healthy group (N = 31) with a mean (m) A′ score of 0.872 ± 0.093. 18 Expected differences were seen; the MSCI group showed lower m A′ scores in all tasks compared to the MSNI group ( Figure 3 ). Differences were also seen in m DMT7 A′ score, DD, and T2 LV between groups (Table 3) . Figures 4 and 5 ). There were no significant differences in DI7 activation between MSNI and MSBD. There were no significant positive or inverse correlations of DI3, DI5, or DI7 activations with II.
A′ versus II scores

Regression of I/DMT activation and T2 LV
In the group of 40 patients (30 MSCI + 10 MSNI), there was a significant inverse correlation of DI7 activation with T2 LV in portions of left middle and Figure 3 . Expected differences were seen between MSNI and MSCI patients. The MSCI group showed lower mean A′ scores in all tasks compared to the MSNI group. MSNI scores were consistent with those seen in a group of previously evaluated healthy, non-MS subjects. superior frontal gyrus, left paracentral lobule, left post-and precentral gyrus, and left SMA (p = 0.005; cluster extent = 657 voxels; average correlation coefficient within the significant cluster was r = −0.42; Figure 6 and Table 4 ). 34 This inverse correlation had 22 voxels in the left superior frontal gyrus which are also voxels in which MSNI subjects had significantly greater DI7 activation than MSCI subjects. When the four MSBD were included in the analysis, there was also a significant inverse correlation of DI7 activation with T2 LV in the same areas (p = 0.002; cluster extent = 798 voxels; r = −0.40). There were no brain regions that showed a positive correlation between T2 LV and DI7 activation. There were no significant positive or inverse correlations with T2 LV and activation during DI3 or DI5. 
Regression of I/DMT activation on DMT A′ scores
In the group of 40, there was a significant positive correlation of DI7 activation with DMT7 A′ scores in portions of the left superior and middle frontal gyrus, left SMA, and left medial superior frontal gyrus (p = 0.002; cluster extent = 837 voxels; r = 0.41; Figure  7 ). No significant inverse correlation was found. No significant positive or inverse correlations were found between DI3 or DI5 WMa with mean A′ scores. In the group of 44, there was also a significant positive correlation of DI7 activation with DMT7 A′ scores in similar areas (p = 0.002; cluster extent = 1280 voxels; r = 0.40). This positive correlation had 264 voxels in the left superior frontal gyrus which are also voxels in which MSNI subjects had significantly greater DI7 activation than MSCI subjects. 
Regression of I/DMT activation on EDSS scores
In the group of 40 patients, there was a significant inverse correlation of DI7 activation with EDSS scores in the following clusters: cluster 1-portions of left hippocampus, left thalamus, left caudate, left putamen, and left lingual gyrus (p = 0.002; cluster extent = 843 voxels; r = −0.44; Figure 8 ) and cluster 2-portions of left middle and inferior frontal gyrus, left and right superior medial frontal gyrus, left and right superior frontal gyrus, left precentral gyrus, and pars opercularis (p < 0.002; cluster extent = 1168 voxels; r = −0.42; Figure 9 ). In the group of 44, there was a significant inverse correlation of DI7 activation with EDSS scores in portions of left caudate, left hippocampus, left lingual gyrus, and left thalamus (p = 0.004; cluster extent = 742 voxels; r = −0.42; Figure 10 ). No correlations were found between DI5 or DI3 and EDSS.
None of the variables age, sex, education, or DD met criteria for entering the stepwise multiple regression model for DI7 activation on EDSS scores. In separate analyses, none of these variables showed a significant individual correlation with DI7 activation (two-tailed FWE-corrected cluster p was >0.10 for each of these correlations). These variables as well as EDSS scores failed to enter the final model for I/DMT activation on T2 LV or on DMT A′ scores.
Retrospective analysis by order of enrollment
The group of the first 15 MSCI patients enrolled, showed greater BOLD activation during DI5 compared to the group of 10 MSNI. This was explained by a higher mean T2 LV, II, and DD than the rest of the MSCI enrolled later (Table 5 ).
Discussion
The combination of NP and fMRI studies provides a new insight for understanding the biological mechanisms responsible for the clinical manifestation of CI in MS. Our results suggest that CI can be detected by the I/DMT in MS. The accurate performance of this paradigm requires intact cognitive abilities for processing of visual information, IP, sustained attention, and WM. In this study, greater BOLD activation during I/DMT was seen in several brain regions, mainly the prefrontal cortex, in the MSNI compared to the MSCI group, during the 7-digit but not during the 3-or 5-digit tasks. Our findings are consistent with results from a recent multicenter trial by Rocca et al., 35 where 42 RR MS patients were evaluated during the N-back load condition, showing that the 22 cognitively preserved patients had increased recruitment of the right dorsolateral prefrontal cortex during the cognitive task. In this study, the greater BOLD activation seen in MSNI also correlated with I/ DMT performance (based on A′ scores), with T2 LV and with EDSS, supporting the notion that a higher lesion load not only correlates with higher disability but may also interfere with connections or input from different brain regions involved in cognition. As T2 LV increases, there seems to be a decrease in the brain's ability to compensate (by either increasing activation or activating additional regions) for the disruption of input to areas involved in performing a cognitive task.
These results extend previous evidence that MS patients consistently recruit additional functional brain areas resulting in increased connectivity and thus show greater BOLD activation, 7 supporting that enhancement of effective neuronal connectivity may provide a compensatory mechanism, and lack of this capability reflects CI. Of interest, preliminary analysis between the first 9 MSNI and 12 MSCI patients enrolled in the study showed differences in BOLD activation during DI5 but not DI7, with greater activation seen in the MSCI. In a retrospective analysis to clarify this issue, the first 15 MSCI patients enrolled were found to have a higher mean II, mean T2 LV, and mean DD compared to the rest of the MSCI patients ( Table 5 ), supporting that I/DMT detects different degrees of CI, as this group of MSCI patient was unable to perform at the DI7 level.
In MS, an increase in task-related BOLD activation has been proposed as a compensatory mechanism that may delay the onset of CI and that exhausts as disease progresses. 10 Our results show that higher T2 LV was associated with less task-related BOLD signal during the highest complexity task, suggesting that an increase in T2 LV may be an underlying mechanism for eventual exhaustion of compensatory activation. The negative correlation found between BOLD activation and EDSS supports the notion that with increased disability, compensatory mechanisms decrease but task complexity plays a role.
Limitations of this study are the small number of patients, the lack of age-sex matched HC, lack of test-retests reliability, and the complexity of I/DMT, which was not feasible to obtain in severe CI. A total of two patients with severe CI were unable to provide correct answers above the 3-digit task, which did not prove useful for CI detection.
In conclusion, the I/DMT fMRI paradigm detects CI in MS based on differences in BOLD activation between MSCI and MSNI patients in brain areas related to WM, attention, and IP. This was supported by concordance in classification as MSNI or MSCI by II from MACFIMS and A′ scores from I/DMT. These findings support that this technique can improve our understanding of CI and may potentially be used in evaluating interventions to improve cortical function and brain plasticity.
